Pre-Exposure Prophylaxis (PrEP)

PrEP (pre-exposure prophylaxis) is medicine people take to prevent getting HIV from sex or injection drug use. This video provides information about PrEP.

This informational video discusses the PrEP pill. It includes verbal narration as well as signed American Sign Language.

This webinar series is a partnership with the Atlanta Black Women Leaders On PrEP and NASTAD. The webinars provide a platform for Black women to share their research with a broader audience and discuss ways the public health community can provide support for their efforts. 

This webinar series is a partnership with the Atlanta Black Women Leaders On PrEP and NASTAD. The webinars provide a platform for Black women to share their research with a broader audience and discuss ways the public health community can provide support for their efforts. 

A sticker sheet of eight stickers in the style of the Together U animated videos that encourage HIV testing, PrEP use and ending HIV stigma, as well as providing QR codes to connect to resources.

The goal of this billing and coding guide is to provide up-to-date information and best practices for coding, billing, and denial resolution for PrEP and PEP services. The intention is that this guide will serve as a foundation from which a healthcare organization can build internal PrEP and PEP coding and billing policies. 

The Ready, Set, PrEP website provides free PrEP HIV-prevention medications to thousands of people living in the United States, including tribal lands and territories that qualify.

This webpage discusses how HIV pre-exposure prophylaxis drugs, otherwise known as PrEP, are powerful weapons against HIV. Through education and raising awareness of HIV exposures, the risks of getting the disease are lower than ever.

The PrEP Cost Sharing Complaint Template is meant to assist providers and patients file a complaint about an uncompliant health plan charging for PrEP services.

This research discusses how PrEP was approved for HIV prevention in the US in 2012; uptake has been slow. Black and Hispanic people have higher rates of new HIV diagnoses than White non-Hispanic people in the US. We describe the inequitable use of PrEP by race within US regions from 2012-2021.